These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22588328)

  • 1. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can).
    Nagel G; Stocks T; Späth D; Hjartåker A; Lindkvist B; Hallmans G; Jonsson H; Bjørge T; Manjer J; Häggström C; Engeland A; Ulmer H; Selmer R; Concin H; Stattin P; Schlenk RF
    Ann Hematol; 2012 Oct; 91(10):1519-31. PubMed ID: 22588328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
    Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.
    Chiu BC; Gapstur SM; Greenland P; Wang R; Dyer A
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2348-54. PubMed ID: 17164355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on metabolic factors and risk of prostate cancer.
    Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
    Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
    Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
    Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
    Bjørge T; Lukanova A; Tretli S; Manjer J; Ulmer H; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Jonsson H; Häggström C; Stattin P; Engeland A
    Int J Epidemiol; 2011 Dec; 40(6):1667-77. PubMed ID: 21984693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can).
    Stocks T; Lukanova A; Bjørge T; Ulmer H; Manjer J; Almquist M; Concin H; Engeland A; Hallmans G; Nagel G; Tretli S; Veierød MB; Jonsson H; Stattin P;
    Cancer; 2011 Jun; 117(11):2398-407. PubMed ID: 24048787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can).
    Almquist M; Johansen D; Björge T; Ulmer H; Lindkvist B; Stocks T; Hallmans G; Engeland A; Rapp K; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
    Cancer Causes Control; 2011 May; 22(5):743-51. PubMed ID: 21380729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
    Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index (BMI) as a major factor in the incidence of the metabolic syndrome and its constituents in unaffected Taiwanese from 1998 to 2002.
    Yang FY; Wahlqvist ML; Lee MS
    Asia Pac J Clin Nutr; 2008; 17(2):339-51. PubMed ID: 18586657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary patterns and markers for the metabolic syndrome in Australian adolescents.
    Ambrosini GL; Huang RC; Mori TA; Hands BP; O'Sullivan TA; de Klerk NH; Beilin LJ; Oddy WH
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):274-83. PubMed ID: 19748245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and endometrial carcinoma.
    Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
    Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
    Lindkvist B; Almquist M; Bjørge T; Stocks T; Borena W; Johansen D; Hallmans G; Engeland A; Nagel G; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
    Cancer Causes Control; 2013 Jan; 24(1):107-16. PubMed ID: 23149498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do sex hormones influence features of the metabolic syndrome in middle-aged women? A population-based study of Swedish women: the Women's Health in the Lund Area (WHILA) Study.
    Shakir YA; Samsioe G; Nyberg P; Lidfeldt J; Nerbrand C; Agardh CD
    Fertil Steril; 2007 Jul; 88(1):163-71. PubMed ID: 17383645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
    Johansen D; Stocks T; Jonsson H; Lindkvist B; Björge T; Concin H; Almquist M; Häggström C; Engeland A; Ulmer H; Hallmans G; Selmer R; Nagel G; Tretli S; Stattin P; Manjer J
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2307-17. PubMed ID: 20826833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.
    Seki S; Tsutsui K; Fujii T; Yamazaki K; Anzawa R; Yoshimura M
    Clin Exp Hypertens; 2010; 32(5):270-7. PubMed ID: 20662727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.